Of the 36 IDH1 wild-type tumor patients, the pathology results of the primary surgery diagnosed 31 cases (86.11%) as GBM, 2 cases (5.56%) as WHO grade 2, and 3 cases (8.33%) as WHO grade 3. The gene discussed is IDH1; the disease is neoplasm.